Asia Pacific Antifungal Drugs Market Size & Outlook
Asia Pacific antifungal drugs market, 2018-2030 (US$M)
Related Markets
Asia Pacific antifungal drugs market highlights
- The Asia Pacific antifungal drugs market generated a revenue of USD 3,479.0 million in 2023.
- The market is expected to grow at a CAGR of 5.3% from 2024 to 2030.
- In terms of segment, azoles was the largest revenue generating drug class in 2023.
- Echinocandins is the most lucrative drug class segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 3,479.0 million |
| Market revenue in 2030 | USD 4,985.7 million |
| Growth rate | 5.3% (CAGR from 2023 to 2030) |
| Largest segment | Azoles |
| Fastest growing segment | Echinocandins |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Azoles, Echinocandins, Polyenes, Allylamines |
| Key market players worldwide | Novartis AG ADR, Pfizer Inc, Bayer AG, Sanofi SA, Merck KGaA, Merck & Co Inc, GlaxoSmithKline, Abbott Laboratories, Enzon Pharmaceuticals Inc, Astellas Pharma Inc, Glenmark Pharmaceuticals |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 22.0% of the global antifungal drugs market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 4,985.7 million by 2030.
Azoles was the largest segment with a revenue share of 47.74% in 2023. Horizon Databook has segmented the Asia Pacific antifungal drugs market based on azoles, echinocandins, polyenes, allylamines covering the revenue growth of each sub-segment from 2018 to 2030.
Large target population base in countries such as China and India. Rising demand for the treatment due to high disease prevalence in the region.
The changing structure of the market in this region due to the acquisition of local companies by multinational players.
Increasing disposable income in developing nations is expected to attract more key players. Increasing investment by major pharmaceutical companies in the region for R&D.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Antifungal Drugs Market Scope
Antifungal Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific antifungal drugs market size, by country, 2018-2030 (US$M)
Asia Pacific Antifungal Drugs Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
